Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia

Mutations in the Cardiac Ryanodine Receptor Gene ( <i>hRyR2</i> ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia

Silvia G. Priori, Carlo Napolitano, Natascia Tiso et al. · Circulation · 2001 · 1.4K citations · Full text

Medicine, Cardiology, Genetics +16

Catecholaminergic Polymorphic Ventricular Tachycardia in Children

Antoine Leenhardt, V. Lucet, Isabelle Denjoy et al. · Circulation · 1995 · 1K citations

Medicine, Cardiology, Pediatrics +11

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Gust H. Bardy, Warren Smith, Margaret Hood et al. · New England Journal of Medicine · 2010 · 774 citations · Full text

Medicine, Biomedical Engineering, Cardiology +9

A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Hadas Lahat, Elon Pras, Tsviya Olender et al. · The American Journal of Human Genetics · 2001 · 649 citations · Full text

Medicine, Cardiology, Genetics +13

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Hiroshi Watanabe, Nagesh Chopra, Derek R. Laver et al. · Nature Medicine · 2009 · 600 citations · Full text

Medicine, Cardiology, Pharmacology +12